Ceylon Hospitals Plc
54.50
LKR
-2.50
(-4.39%)
ISIN
LK0338N00000
Return %
Stock
S&P 500
1Y
4.81
14.20
3Y
79.86
81.12
5Y
73.83
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Lasantha Karunasekara
- Full Time Employees
- 2,072
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Colombo Sri Lanka
- IPO Date
- Nov 14, 2003
- Website
- durdans.com
- Similar Companies
- Business
- Ceylon Hospitals PLC is a Sri Lanka-based tertiary healthcare provider that owns and operates the multi-specialty private healthcare network under the Durdans Hospital brand. Founded in 1939 and headquartered in Colombo, Sri Lanka, the company operates as a subsidiary of Durdans Management Services Ltd and serves domestic and international patients across outpatient, inpatient, emergency, and diagnostic domains. The company manages its operations through specialized business segments, including clinical and surgical care, nationwide medical laboratory diagnostics, healthcare education, and biotechnology distribution. The company provides an extensive portfolio of medical, surgical, and diagnostic services; cardiology and cardiothoracic surgery through the specialized Durdans Heart Centre, offering coronary artery bypass grafting, angiographies, angioplasties, catheterization procedures, and electrophysiology studies; general, laparoscopic, orthopedic, neurological, oncological, ENT, and urological surgical procedures; round-the-clock emergency medical support, trauma management, and intensive care units including CCU, ICU, and NICU facilities; maternity, pediatric, and specialized women and childcare services; nephrology and hemodialysis care; comprehensive medical imaging and radiology services, such as 3T MRI, 128-slice CT scans, digital mammography, X-ray, and ultrasound diagnostics; extensive pathology and laboratory diagnostic services spanning molecular diagnostics, clinical chemistry, histopathology, microbiology, and haematology, delivered through a multi-center island-wide network of Durdans Laboratory branches and mobile sample collection units; in-hospital and retail pharmacy operations; executive health screening and corporate wellness packages; physiotherapy and physical rehabilitation; allied healthcare training and higher education diplomas in nursing, biomedical sciences, and radiology via its subsidiary Amrak Institute of Medical Sciences (Pvt) Ltd; and molecular diagnostic reagents and biotech supplies through its subsidiary Ceygen Biotech (Pvt) Ltd. The company also oversees dedicated operational subsidiaries, including Durdans Medical and Surgical Hospital (Pvt) Ltd and Durdans Heart Surgical Centre (Pvt) Ltd. In recent operational and strategic developments, Ceylon Hospitals PLC has accelerated its digital transformation, expanded diagnostic reach, and undertaken capital restructuring. The company implemented an enterprise-wide Enterprise Resource Planning (ERP) platform across its hospital network and laboratory chain to streamline patient management and optimize operating efficiencies. To strengthen home healthcare and remote patient accessibility, the company entered into a strategic collaboration with MediPlace to offer on-demand home sample collection and integrated digital diagnostic reporting. In early 2026, the company announced a four-for-one share sub-division for both its voting and non-voting shares on the Colombo Stock Exchange to enhance share liquidity and broaden shareholder participation. Concurrently, the organization strengthened its medical governance with executive clinical appointments, upgraded critical diagnostic infrastructure, and broadened academic accreditation pathways through the Amrak Institute of Medical Sciences to address regional healthcare staffing requirements.